The San Diego, USA firm has simultaneously announced that the US Food and Drug Administration (FDA) has granted Orphan Drug ...

Swedish drug developer BioArctic shot up 14.5% to 269.20 kronor on the news of a license and collaboration deal with Swiss ...

MannKind Corporation yesterday signed a definitive agreement to acquire fellow USA-based scPharmaceuticals, with the news ...

California, USA-based Protagonist Therapeutics yesterday revealed that its rusfertide, a potential first-in-class ...

The Roche subsidiary Genentech has broken ground on its newest US production site in Holly Springs, North Carolina, marking ...

The US eosinophilic esophagitis (EoE) market is projected to grow from $202 million in 2020 to $1.19 billion in 2030, ...

Russian drugmaker R-Pharm is searching buyers for its flagship factory in Germany in the city of Illertissen, which was ...

Dutch immunology company argenx has announced positive top-line data from the pivotal ADAPT SERON Phase III study of Vyvgart ...

Founded in 2016 and headquartered in San Francisco, Multiply Labs designs robotic manufacturing systems for personalized ...

The US Food and Drug Administration on Friday revealed it has begun daily publication of adverse event data from the FDA ...

Shares in Biohaven moved up about 7% on Friday after the company provided an update with respect to its New Drug Application (NDA) for troriluzole for the treatment of adult patients with ...

The European Commission has approved a new film-coated tablet formulation of Sino-American oncology-focused biotech BeOne Medicines’ Brukinsa (zanubrutinib) for all approved indications.